TNFRSF11B and rheumatoid arthritis: On the other side, GC is often used in the treatment of RA, which can determine bone loss by the following two mechanisms: first, by the inhibitory effect on bone formation, and second, by increasing bone resorption due to an improper function of the RANK-L/osteoprotegerin (OPG) system [3].